Diazepam Injection, Solution
NDC Package 72572-140-02

11-digit billing NDC: 72572014002 · Billing unit: ML · 20 ML per package

Package Information

Diazepam injection is diazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. This formulation utilizes a injection, solution delivery system. Marketed by Civica, Inc., this product is identified by NDC 72572-140 and is authorized under FDA application ANDA210363.

Identification & Billing

NDC Package Code
72572-140-02
Package Description
10 SYRINGE, GLASS in 1 CARTON / 2 mL in 1 SYRINGE, GLASS (72572-140-01)
Product Code
11-Digit Billing Format
72572014002
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
20 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Diazepam
Non-Proprietary Name
Diazepam
Substance Name
Diazepam
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Usage Information
Diazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic.In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis.As an adjunct prior to endoscopic procedures if apprehension, anxiety or acute stress reactions are present, and to diminish the patient's recall of the procedures (see WARNINGS).Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma); spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff-man syndrome; and tetanus.Diazepam injection is a useful adjunct in status epilepticus.Diazepam is a useful premedication (the intramuscular route is preferred) for relief of anxiety and tension in patients who are to undergo surgical procedures. Intravenously, prior to cardioversion for the relief of anxiety and tension and to diminish the patient's recall of the procedure.
DEA Schedule
Schedule IV (CIV) Substances

Regulatory & Marketing

Labeler Name
Civica, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA210363
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-01-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

Source: ASP
Diazepam injection
HCPCS Dosage 5 MG
Units / Pkg 20

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72572-140-02 identifies a specific commercial package of 10 syringe, glass in 1 carton / 2 ml in 1 syringe, glass (72572-140-01) of Diazepam, a human prescription drug labeled by Civica, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 20 billable units per package. This injection, solution is formulated for intramuscular; intravenous use and contains diazepam as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Civica, Inc. on December 01, 2019. The current certification is valid through December 31, 2026.

How is this Civica, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72572014002. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 20 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72572-140-02
11-Digit CMS (5-4-2)
72572-0140-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.